alloxan has been researched along with Tauopathies in 1 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alloxan treatment reduced HSP90 levels and promoted proteasomal degradation of tau, c-Jun N-amino terminal kinase, and histone deacetylase (HDAC) 6." | 1.38 | Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes. ( Kimura, T; Maeda, S; Mizoroki, T; Murayama, M; Sahara, N; Soeda, Y; Takashima, A; Yamashita, S; Yoshiike, Y, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshiike, Y | 1 |
| Yamashita, S | 1 |
| Mizoroki, T | 1 |
| Maeda, S | 1 |
| Murayama, M | 1 |
| Kimura, T | 1 |
| Sahara, N | 1 |
| Soeda, Y | 1 |
| Takashima, A | 1 |
1 other study available for alloxan and Tauopathies
| Article | Year |
|---|---|
Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
Topics: Acetylation; Adaptation, Physiological; Aging; Alloxan; Animals; Disease Models, Animal; Female; His | 2012 |